The second edition of Global Congress on Population, Health & Human Development «PHDC 24» was held under the auspices of President Abdel Fattah Al-Sisi in Cairo. ACDIMA Company, headed by Dr. Olfat Ghorab, and a delegation from ACDIMA sister and affiliated companies attended.

A strong presence of “ACDIMA” at “CPHI”, Milan, the largest and most important exhibition in the world for the pharmaceutical industries

The third African Medical Conference and Exhibition «Africa Health ExCon» was held under the auspices of President Abdel Fattah Al-Sisi from June 3 to 6, 2024 in Cairo. Acdima Company, headed by Dr. Olfat Ghorab, and a delegation from Acdima sister and affiliated companies attended

Dr. Olfat Ghorab, Chairman of ACDIMA, received a delegation from Super-pharm LLP from Kazakhstan, headed by MR. Kairat Kaimoldayev the CEO.

Dr. Khaled Abdel Ghaffar, Minister of Health and Population, announced the start of a new phase of fruitful cooperation between Egypt and Cuba, by exporting Egyptian human insulin, known as “Insulinagypt,” from Egypt to Cuba.

Dr. Olfat Ghorab: We are implementing a comprehensive strategy to localize the pharmaceutical industry in Egypt with the strength of our financial and operational structure and the absolute support of the country.

The Minister of Health emphasizes the role of “ACDIMA” in developing and localizing pharmaceutical industries in accordance with the latest international standards.

During the company’s general assembly meeting, Dr. Olfat Ghorab, Chairman of the Board of Directors of the Arab Company for Drug Industries and Medical Appliances “ACDIMA”, reviewed ACDIMA’s efforts and achievements during the year 2023, which was achieved to meet the pharmaceutical needs in the Egyptian market and implementing strategies to serve patients.

Under the auspices of “Acdima International” … “The Ministry of Health” launches the largest training program for gynecologists and obstetrics.

Winners of ACDIMA Award receiving their award at ACDIMA.

A delegation from the largest pharmacy company in Kazakhstan visits ACDIMA to discuss joint cooperation.

“ACDIMA” One of the Largest Pharmaceutical Holdings in the Middle East is Planning to Build a Plant in Kazakhstan

National Day of Egypt

Tashkent – July 17,2023

31 Years of diplomatic relations between Egypt and Uzbekistan.

ACDIMA signs a cooperation protocol with “Aamal Holding – Qatar” to transfer pharmaceutical manufacturing technology and promote Egyptian medicine in Qatar.

In a step that contributes to achieving national and health security
SEDICO Pharmaceutical Industries, one of the companies of the ACDIMA Group, begins the trial operation of the first factory for the production of oncology drugs in Egypt, with investments up to one billion pounds.

The Minister of Health visits SEDICO’s factory, which specializes in the production of cytotoxics preparations.

The Minister of Health inspects MUP Tech factory specialized in Insulin VL & Carpules.

A protocol of co-operation was signed between ACDIMA and SRTA-City.

The signature of cooperation protocol between City of Scientific Research and Technological Applications and ACDIMA which is known for its great support for educational institutions in the fields of training and scientific research.

A protocol of co-operation was signed between ACDIMA and FUE.

The signature of cooperation protocol between FUE and ACDIMA which is known for its great support for educational institutions in the fields of training and scientific research.

ACDIMA is an Egyptian investment corporate specialized in healthcare industries. We have successfully secured the availability of essential pharmaceutical products through; integration, self-sufficiency and reasonably priced products.

Over the recent years ACDIMA became the strongest arm supporting the Egyptian Pharmaceutical industries. ACDIMA products exist in 55 countries in Europe, CIS, Africa and the Middle East.

Research and Development is one of the main pillars to improve Egypt’s social and economical position, that’s why ACDIMA is focused on enhancing Egyptian research and development by providing our annual ACDIMA Award in science and applied pharmaceutical industry to winners.

ACDIMA is coordinating and cooperating with the Ministry of Health and relevant authorities, such as the Egyptian Medicines Authority and the Unified Procurement Authority, in providing some strategic and essential medicines for the Egyptian patient, as well as medicines that have a noticeable shortage in the local medicine market, by producing some medicines similar to these deficiencies and doubling production quantities with import for others if non-manufacturing.